Top compounds associated with response to CRYBA2


Feature Type Standardized
Nominal ANOVA
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0002
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA Elesclomol GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA indisulam CTRPv2 pan-cancer AAC 0.12 0.0002
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA FH535 GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA hyperforin CTRPv2 pan-cancer AAC 0.14 0.0002
Download CSV